# Saccharomyces Boulardii as Pretreatment Before Rescue Therapy of Helicobacter Pylori

> **NCT05191875** · NA · COMPLETED · sponsor: **The Third Xiangya Hospital of Central South University** · enrollment: 106 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Saccharomyces Boulardii 250 MG
- **DRUG:** Ilaprazole.Doxycycline. Furazolidone. Colloidal Bismuth Tartrate

## Key facts

- **NCT ID:** NCT05191875
- **Lead sponsor:** The Third Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-01
- **Primary completion:** 2022-04-12
- **Final completion:** 2022-04-23
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2022-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05191875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05191875, "Saccharomyces Boulardii as Pretreatment Before Rescue Therapy of Helicobacter Pylori". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05191875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*